MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO

Contributed by: Business Wire

Logo

Tags

Research

Medical Devices

Health Technology

Professional Services

Biotechnology

Data Analytics

Pharmaceutical

Health

Science

Other Science

Exploristics

More Like This

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization

Kester Capital backs experienced management team in acquiring EMAS Pharma

Zamas Lam, PhD, Global Head of Bioanalytical (Mass Spec) & Preclinical Development, QPS LLC. (Photo: Business Wire)

QPS Significantly Enhances Mass Spectrometry Laboratory Capacity

PR Newswire associated0

ExoAnalytic Solutions Announces Planned Acquisition of UK Startup 3S Northumbria

PR Newswire associated0

PCM Trials Acquires Netherlands-Based Clinical Trial Service B.V., Becoming the Most Experienced Independent Provider of Mobile Visit Services with The Largest Geographic Coverage Area in Support of Decentralized Clinical Trials

PR Newswire associated0

Calyx and Invicro agree to combine to create a global leader in medical imaging and software solutions for the clinical research community

MSCI Completes Acquisition of Foxberry

MSCI Expands Custom Index Offering With Acquisition of Foxberry